Carvedilol Tablet, Film Coated
Product Images NDC 63187-941

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 63187-941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Survival Analysis For Copernicus (intent-to-treat) (Carvedilol Fig1)

A line graph titled 'Survival Analysis for COPERNICUS (Intent-to-Treat)' depicting % mortality on the vertical axis and months on the horizontal axis. Two curves compare mortality rates over time between placebo and carvedilol groups, with a p-value of 0.004 shown.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Fig2)

A forest plot figure titled 'Effects on Mortality for Subgroups in COPERNICUS' showing hazard ratios with confidence intervals for various subgroups such as men, women, age groups, racial categories, diabetic status, heart rate, systolic blood pressure, and spironolactone use. The horizontal axis represents hazard ratios from 0.0 to 2.0, with a vertical reference line at 1.0.*

FDA Label Image

Figure 3. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig3)

A survival analysis line graph for CAPRICORN (Intent-to-Treat) comparing mortality percentage over 24 months between Carvedilol and Placebo groups. The x-axis represents time in months, and the y-axis shows the percentage mortality. The graph includes a p-value of 0.03 indicating statistical significance.*

FDA Label Image

Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig4)

A figure titled 'Effects on Mortality for Subgroups in CAPRICORN' displaying hazard ratios for different patient subgroups. The chart compares mortality effects across variables such as age, sex, timing of randomization post-myocardial infarction, prior beta-blocker use, Killip class, thrombolytic therapy, PTCA intervention, presence of congestive heart failure, use of diuretics, angina status, hypertension, diabetes, heart rate, systolic blood pressure, and all patients combined. Horizontal lines denote confidence intervals around hazard ratio points.*

FDA Label Image

63187-941-60 (Carvedilol Fig5)

Label for Carvedilol 3.125 mg film-coated tablets, quantity 60, from Proficient Rx LP. Tablets are white to off-white, oval-shaped, debossed with 'E' on one side and '01' on the other. Product ID PC094160, manufactured by Aurobindo Pharma Limited Hyderabad, India. Storage instructions and lot/expiration placeholders are visible.*

FDA Label Image

Chemical Structure (Carvedilol Str)

Chemical structure of Carvedilol, an active ingredient in the drug Carvedilol. The diagram shows the molecular arrangement including hydroxyl (OH), methoxy (OCH3), and indole groups characteristic of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.